Angiogenesis is a critical process for tumorigenesis: inhibiting the activity of VEGFR1 or VEGFR3 reduces the proliferation of breast or colorectal cancer cell lines in vitro and inhibits tumor growth in vivo [33–36]. The gene discussed is FLT1; the disease is colorectal cancer.